Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Bronchial Neoplasms × trametinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 19 Neoplasms 17 Carcinoma, Non-Small-Cell Lung 10 Neoplasm Metastasis 8 Colorectal Neoplasms 8 Pancreatic Neoplasms 7 Rectal Neoplasms 4 Triple Negative Breast Neoplasms 3 Lung Neoplasms 3 Colonic Neoplasms 3 Thyroid Neoplasms 2 Multiple Myeloma 2 Meningioma 2 Glioma 2 Breast Neoplasms 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Thyroid Carcinoma, Anaplastic 1 Thrombocytosis 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors, KRAS Mutation; SOS1 1 Solid Tumors 1 Solid Tumor Cancer 1 Solid Tumor 1 Sarcoma 1 Rhabdoid Tumor 1 Relapsed Metastatic KRAS-Mutated Non-Small Cell Lung Cancer 1 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Prostatic Neoplasms 1

Interventions

entinostat 3 osimertinib 2 Pemetrexed 2 Carboplatin 2 trametinib 1 pembrolizumab 1 nazartinib 1 exemestane 1 Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03516214 2024-02-15

EATON

University of Cologne

Phase 1 Completed

Bronchial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡